Instil Bio, Inc. (TIL) Revenue History
Annual and quarterly revenue from 2019 to present
TIL Revenue Over Time (2019–2025)
TIL Revenue Growth History
0 of 1 years with positive growth- FY2019 revenue growth
- N/A
- FY2020 revenue growth
- N/A
- FY2021 revenue growth
- -100.0%
- FY2022 revenue growth
- N/A
- FY2023 revenue growth
- N/A
- FY2024 revenue growth
- N/A
- FY2025 revenue growth
- N/A
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $0 | — |
| Q4 2025 | $0 | — |
| Q3 2025 | $0 | — |
| Q2 2025 | $0 | — |
| Q1 2025 | $0 | — |
| Q4 2024 | $0 | — |
| Q3 2024 | $0 | — |
| Q2 2024 | $0 | — |
TIL Revenue Analysis (2019–2025)
Current Revenue & Growth
As of June 13, 2026, Instil Bio, Inc. (TIL) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q1 2026) recorded $0 in revenue
Historical Growth Trajectory
TIL's historical revenue data shows various trends over time. Instil Bio, Inc.'s highest annual revenue of $138,000 was recorded in 2020.
Peer Comparison
Compared to Healthcare sector peers — including IOVA (+34.3% YoY), ADCT (+4.4% YoY), and FATE (-52.6% YoY). Compare TIL vs IOVA →
TIL Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
 TILCurrent | $0 | - | - | - | |
 IOVA | $264M | +34.3% | - | -153.1% | |
 ADCT | $81M | +4.4% | - | -133.2% | |
 FATE | $7M | -52.6% | -26.7% | -2222.4% | |
 TGTX | $616M | +81.3% | +426.7% | 20.0% | |
 CRIS | $9M | -36.9% | -2.7% | -348.4% |
TIL Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $-534,000 | - | $-52,907,000 | - |
| 2024 | $0 | - | $0 | - | $-73,541,000 | - |
| 2023 | $0 | - | $0 | - | $-159,169,000 | - |
| 2022 | $0 | - | $-5,987,000 | - | $-206,170,000 | - |
| 2021 | $0 | -100.0% | $0 | - | $-155,560,000 | - |
| 2020 | $138K | - | $138K | 100.0% | $-33,644,000 | -24379.7% |
| 2019 | $0 | - | $-20,000 | - | $-6,585,000 | - |
What if you invested $1,000 in TIL back in 2019?
Total return with dividends reinvested · 7+ years of data
Calculate ReturnsHow much would $100/month in TIL be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs TIL Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationTIL vs LLY — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs Eli Lilly and Company.
Compare NowTIL — Frequently Asked Questions
Quick answers to the most common questions about buying TIL stock.
Is TIL's revenue growth accelerating or slowing?
TIL TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is TIL's revenue history from 2019 to 2026?
Instil Bio, Inc. (TIL) revenue history spans 2019 to 2026. TTM revenue as of 2026 is $0.00, growing at N/A YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is TIL's long-term revenue growth rate (CAGR)?
Instil Bio, Inc.'s 5-year revenue CAGR of N/A reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of N/A is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for TIL.
Why does TIL's quarterly revenue fluctuate?
TIL quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Instil Bio, Inc.'s revenue data from 2019 to 2026 shows full historical quarterly detail on this page.
How is TIL's revenue distributed by segment?
TIL reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does TIL's revenue compare to industry peers?
Instil Bio, Inc. (TIL) with TTM revenue of $0.00 and N/A YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.